Methoxyamine and Temozolomide in Treating Patients With Recurrent Glioblastoma
Status:
Terminated
Trial end date:
2017-02-16
Target enrollment:
Participant gender:
Summary
This phase II trial studies how well methoxyamine works when added to standard temozolomide
in treating patients with glioblastoma that has come back. Drugs used in chemotherapy, such
as methoxyamine and temozolomide, work in different ways to stop the growth of tumor cells,
either by killing the cells, by stopping them from dividing, or by stopping them from
spreading.